Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Profitability Summary
Hubei Biocause Pharmaceutical Co Ltd's profitability score is 17/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Margins Comparison
Hubei Biocause Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
13.5B CNY |
-2%
|
|
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
172.6B Zac |
17%
|
|
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
137.7B Zac |
10%
|
|
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
937.1B CNY |
14%
|
|
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
116.1B Zac |
12%
|
|
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
783.8B CNY |
37%
|
|
| HK |
|
AIA Group Ltd
HKEX:1299
|
664.3B HKD |
30%
|
|
| US |
|
Aflac Inc
NYSE:AFL
|
58.4B USD |
29%
|
|
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
5T INR |
5%
|
|
| CA |
|
Manulife Financial Corp
TSX:MFC
|
74.1B CAD |
14%
|
|
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
53.4B Zac |
5%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Return on Capital Comparison
Hubei Biocause Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ||
|---|---|---|---|---|---|---|
| CN |
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
13.5B CNY |
-4%
|
0%
|
|
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
172.6B Zac |
23%
|
2%
|
|
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
137.7B Zac |
14%
|
3%
|
|
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
937.1B CNY |
13%
|
1%
|
|
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
116.1B Zac |
32%
|
13%
|
|
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
783.8B CNY |
23%
|
2%
|
|
| HK |
|
AIA Group Ltd
HKEX:1299
|
664.3B HKD |
17%
|
2%
|
|
| US |
|
Aflac Inc
NYSE:AFL
|
58.4B USD |
23%
|
4%
|
|
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
5T INR |
54%
|
1%
|
|
| CA |
|
Manulife Financial Corp
TSX:MFC
|
74.1B CAD |
10%
|
1%
|
|
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
53.4B Zac |
13%
|
1%
|
You don't have any saved screeners yet
